KAT6A occurs in a protein complex with the chromatin adaptor proteins BRPF1, BRPF2, or BRPF3, ING4 or ING5, and MEAF6 (Doyon et al, 2006)
This distinction helps explain the more pronounced weight reduction typically observed with GLP-1 receptor agonists
Trulicity also carries a boxed warning that it can potentially cause thyroid C-cell tumors in rats, though its unknown if this risk translates to humans
However, their services are FSA and HSA eligible, which allows you to use pre-tax dollars for payment
Applied in experimental setups involving receptor interactions
It contributes to early satiety and weight loss, but also underlies many of the adverse effects and emergency department presentations associated with these medications